Channa A. Hewamadduma
Sheffield, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Letter to the editor in response to: Mortality associated with facioscapulohumeral muscular dystrophy: A systematic literature review: Mortality in FSHD: a call for epidemiological research.
Journal: Journal of the neurological sciences
Published: June 22, 2026
In response to: Personalized antioxidant supplementation improves muscle strength, physical activity, and quality of life in patients with FSHD1: A real-world longitudinal study. Laoudj-Chenivesse D, Arbogast S, Raynaud De Mauverger E, Fedou C, Debroize E, Hugon G, Pincemail J, Picot MC, Cristol JP, Mercier J, Portet F. Free Radic Biol Med. 2026 Feb 28; 248: 424-435.
Journal: Free radical biology & medicine
Published: April 26, 2026
Systematic review of outcome measures in facioscapulohumeral dystrophy (FSHD): validated, usable, and feasible tools for assessing function, performance, and strength.
Journal: Neuromuscular disorders : NMD
Published: April 18, 2026
Access to care for adults living with spinal muscular atrophy in the UK.
Journal: BMJ neurology open
Published: February 21, 2026
Respiratory insufficiency and sleep impairment in facioscapulohumeral muscular dystrophy.
Journal: Neuromuscular disorders : NMD
Published: February 09, 2026
Measuring health-related quality of life in facioscapulohumeral muscular dystrophy: a COSMIN systematic review and conceptual framework.
Journal: Health and quality of life outcomes
Published: November 26, 2025
Frequent co-occurrence of AChR-positive myasthenia gravis in facioscapulohumeral muscular dystrophy suggests a novel disease association.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: September 03, 2025
ENGAGE: Analyzing the value of virtual reality in a patient-centric immersive learning program in myasthenia gravis for healthcare professionals.
Journal: Frontiers in neurology
Published: June 27, 2025
What Patients Don't Say and Physicians Don't Ask: A Needs Assessment in Myasthenia Gravis Integrating Patient and Healthcare Professional Perspectives.
Journal: Neurology and therapy
Published: February 21, 2025
Changes in corticosteroid and non-steroidal immunosuppressive therapy with long-term zilucoplan treatment in generalized myasthenia gravis.
Journal: Journal of neurology
Published: February 14, 2025
Diagnosis and Management of Multifocal Motor Neuropathy in the United Kingdom: A Multicentre Survey.
Diagnosis and Management of Multifocal Motor Neuropathy in the United Kingdom: A Multicentre Survey.
Journal: Journal of the peripheral nervous system : JPNS
Published: January 31, 2025
Last Updated: 09/26/2026